PAPER Jia X, Chen Q, Yao C, Asakawa T, Zhang Y

α-synuclein regulates Cyclin D1 to promote abnormal initiation of the cell cycle and induce apoptosis in dopamine neurons.

Biomed Pharmacother. 2024 Apr;173:116444. Epub 2024 Mar 18 PubMed.

PAPER Tan S, Wu L, Liu J, Wu Z, Cheng Q, Qu Q, Zhu L, Yan Y, Wu H, Ling TJ, Liu RT, Yang S

Quercetin-3-O-glc-1-3-rham-1-6-glucoside decreases Aβ production, inhibits Aβ aggregation and neurotoxicity, and prohibits the production of inflammatory cytokines.

Eur J Pharmacol. 2024 May 5;970:176491. Epub 2024 Mar 19 PubMed.

PAPER Schwab K, Frahm S, Magbagbeolu M, Horsley D, Goatman EA, Melis V, Theuring F, Ishaq A, Storey JM, Harrington CR, Wischik CM, Riedel G

LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy.

Eur J Pharmacol. 2024 May 5;970:176505. Epub 2024 Mar 18 PubMed.

PAPER Arar S, Haque MA, Bhatt N, Zhao Y, Kayed R

Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation.

ACS Chem Neurosci. 2024 Apr 3;15(7):1366-1377. Epub 2024 Mar 19 PubMed.

PAPER Everett J, Brooks J, Tjendana Tjhin V, Lermyte F, Hands-Portman I, Plascencia-Villa G, Perry G, Sadler PJ, O'Connor PB, Collingwood JF, Telling ND

Label-Free In Situ Chemical Characterization of Amyloid Plaques in Human Brain Tissues.

ACS Chem Neurosci. 2024 Apr 3;15(7):1469-1483. Epub 2024 Mar 19 PubMed.

PAPER Yuan Y, Mao X, Pan X, Zhang R, Su W

Kinetic Ensemble of Tau Protein through the Markov State Model and Deep Learning Analysis.

J Chem Theory Comput. 2024 Apr 9;20(7):2947-2958. Epub 2024 Mar 19 PubMed.

PAPER Al-Kuraishy HM, Fahad EH, Al-Windy S, El-Sherbeni SA, Negm WA, Batiha GE

The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review.

Inflammopharmacology. 2024 Apr;32(2):917-925. Epub 2024 Mar 18 PubMed.

PAPER Kok EH, Paetau A, Martiskainen M, Lyytikäinen LP, Lehtimäki T, Karhunen P, Myllykangas L

Accumulation of Lewy-Related Pathology Starts in Middle Age: The Tampere Sudden Death Study.

Ann Neurol. 2024 May;95(5):843-848. Epub 2024 Mar 19 PubMed.

PAPER Huang SY, Zhang YR, Guo Y, Du J, Ren P, Wu BS, Feng JF, Alzheimer's Disease Neuroimaging Initiative, Cheng W, Yu JT

Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.

Alzheimers Dement. 2024 May;20(5):3251-3269. Epub 2024 Mar 19 PubMed.

PAPER Coronel-Oliveros C, Gómez RG, Ranasinghe K, Sainz-Ballesteros A, Legaz A, Fittipaldi S, Cruzat J, Herzog R, Yener G, Parra M, Aguillon D, Lopera F, Santamaria-Garcia H, Moguilner S, Medel V, Orio P, Whelan R, Tagliazucchi E, Prado P, Ibañez A

Viscous dynamics associated with hypoexcitation and structural disintegration in neurodegeneration via generative whole-brain modeling.

Alzheimers Dement. 2024 May;20(5):3228-3250. Epub 2024 Mar 19 PubMed.

PAPER Qi Y, Wang X, Guo X

miR-3940-5p reduces amyloid β production via selectively targeting PSEN1.

Front Aging Neurosci. 2024;16:1346978. Epub 2024 Mar 4 PubMed.

PAPER Leinenga G, To XV, Bodea LG, Yousef J, Richter-Stretton G, Palliyaguru T, Chicoteau A, Dagley L, Nasrallah F, Götz J

Scanning ultrasound-mediated memory and functional improvements do not require amyloid-β reduction.

Mol Psychiatry. 2024 Mar 18; PubMed. Correction.

PAPER Wang X, Dong T, Li X, Yu W, Jia Z, Liu Y, Yang J

Global biomarker trends in Parkinson's disease research: A bibliometric analysis.

Heliyon. 2024 Mar 30;10(6):e27437. Epub 2024 Mar 6 PubMed.

PAPER Zhang J, Shi Y

Personalized Patch-based Normality Assessment of Brain Atrophy in Alzheimer's Disease.

Med Image Comput Comput Assist Interv. 2023 Oct;14224:55-62. PubMed.

PAPER Frontiers Editorial Office

Retraction: CSF p-tau as a potential cognition impairment biomarker in ALS.

Front Neurol. 2024;15:1392563. Epub 2024 Mar 4 PubMed. Retracted Paper.